The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells

The Latest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells

Epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor involved in homeostatic regulation of normal cells and carcinogenesis of epithelial malignancies. With rapid development of the precision medicine era, a series of new therapies targeting EGFR are underway. Four EGFR monoclonal an...

Full description

Bibliographic Details
Main Authors: Wen-Qi Cai, Li-Si Zeng, Li-Feng Wang, Ying-Ying Wang, Jun-Ting Cheng, Ying Zhang, Zi-Wen Han, Yang Zhou, Shao-Li Huang, Xian-Wang Wang, Xiao-Chun Peng, Ying Xiang, Zhaowu Ma, Shu-Zhong Cui, Hong-Wu Xin
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
monoclonal antibodies
non-coding RNA
tumor microenvironment
epidermal growth factor receptor
resistance
exosomes
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01249/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01249/full

Similar Items